STE STERIS plc

Price (delayed)

$207.89

Market cap

$20.81B

P/E Ratio

83.16

Dividend/share

$1.72

EPS

$2.5

Enterprise value

$23.74B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
The company's equity has surged by 68% YoY
STE's gross profit has surged by 50% year-on-year and by 11% since the previous quarter
STERIS's debt has soared by 82% YoY but it has decreased by 6% from the previous quarter
STE's P/E is 86% above its 5-year quarterly average of 44.7 and 6% above its last 4 quarters average of 78.5
The company's EPS fell by 46% YoY and by 14% QoQ

Key stats

What are the main financial stats of STE
Market
Shares outstanding
100.08M
Market cap
$20.81B
Enterprise value
$23.74B
Valuations
Price to earnings (P/E)
83.16
Price to book (P/B)
3.19
Price to sales (P/S)
4.54
EV/EBIT
58.59
EV/EBITDA
24.77
EV/Sales
5.18
Earnings
Revenue
$4.59B
EBIT
$405.11M
EBITDA
$958.22M
Free cash flow
$398.99M
Per share
EPS
$2.5
Free cash flow per share
$3.98
Book value per share
$65.24
Revenue per share
$45.79
TBVPS
$36.86
Balance sheet
Total assets
$11.42B
Total liabilities
$4.88B
Debt
$3.28B
Equity
$6.53B
Working capital
$956.78M
Liquidity
Debt to equity
0.5
Current ratio
2.04
Quick ratio
1.24
Net debt/EBITDA
3.06
Margins
EBITDA margin
20.9%
Gross margin
44%
Net margin
5.3%
Operating margin
9.3%
Efficiency
Return on assets
2.1%
Return on equity
3.7%
Return on invested capital
6.8%
Return on capital employed
3.9%
Return on sales
8.8%
Dividend
Dividend yield
0.83%
DPS
$1.72
Payout ratio
68.8%

STE stock price

How has the STERIS stock price performed over time
Intraday
2.69%
1 week
7.84%
1 month
-9.05%
1 year
1.84%
YTD
-14.59%
QTD
-14.01%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$4.59B
Gross profit
$2.02B
Operating income
$425.62M
Net income
$243.89M
Gross margin
44%
Net margin
5.3%
STERIS's net margin has plunged by 59% YoY and by 20% from the previous quarter
STE's gross profit has surged by 50% year-on-year and by 11% since the previous quarter
The revenue has grown by 48% YoY and by 8% from the previous quarter
STE's operating margin is down by 47% year-on-year and by 18% since the previous quarter

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
83.16
P/B
3.19
P/S
4.54
EV/EBIT
58.59
EV/EBITDA
24.77
EV/Sales
5.18
STE's P/E is 86% above its 5-year quarterly average of 44.7 and 6% above its last 4 quarters average of 78.5
The company's EPS fell by 46% YoY and by 14% QoQ
The company's equity has surged by 68% YoY
STE's P/B is 3.3% below its 5-year quarterly average of 3.3 and 3.3% below its last 4 quarters average of 3.3
The revenue has grown by 48% YoY and by 8% from the previous quarter
The P/S is 16% below the last 4 quarters average of 5.4 but 8% above the 5-year quarterly average of 4.2

Efficiency

How efficient is STERIS business performance
STERIS's ROA has plunged by 68% YoY and by 22% from the previous quarter
The ROE has plunged by 65% YoY and by 21% from the previous quarter
STERIS's ROIC has plunged by 60% YoY and by 20% from the previous quarter
The company's return on sales has shrunk by 51% YoY and by 19% QoQ

Dividends

What is STE's dividend history
DPS
$1.72
Dividend yield
0.83%
Payout ratio
68.8%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 134% more than the total liabilities
STE's total liabilities has surged by 82% year-on-year but it is down by 3.7% since the previous quarter
The total assets has soared by 74% YoY but it has contracted by 2.3% from the previous quarter
STERIS's debt is 50% less than its equity
STERIS's debt has soared by 82% YoY but it has decreased by 6% from the previous quarter
The company's equity has surged by 68% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.